Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · IEX Real-Time Price · USD
2.320
+0.210 (9.95%)
At close: May 8, 2024, 4:00 PM
2.370
+0.050 (2.16%)
After-hours: May 8, 2024, 6:19 PM EDT
CYCC's stock price has decreased by -71.8% in the past year and price targets may not have had time to catch up.
Cyclacel Pharmaceuticals Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$65.50
Upside
+2,723.28%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Maintains $21 → $11 | Strong Buy | Maintains | $21 → $11 | +374.14% | May 3, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 19, 2023 |
| Roth MKM | Roth MKM | Strong Buy Maintains $16 → $21 | Strong Buy | Maintains | $16 → $21 | +805.17% | Dec 19, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $120 | Buy | Maintains | $120 | +5,072.41% | May 25, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $150 → $120 | Buy | Maintains | $150 → $120 | +5,072.41% | Mar 7, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $255 | Buy | Initiates | $255 | +10,891.38% | Jul 18, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates $255 | Buy | Initiates | $255 | +10,891.38% | Apr 30, 2021 |